NeoGenomics
256 hedge funds and large institutions have $1.2B invested in NeoGenomics in 2025 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 74 increasing their positions, 91 reducing their positions, and 35 closing their positions.
508% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $1.78M
20% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 35
2.77% more ownership
Funds ownership: 95.56% → 98.33% (+2.8%)
1% more funds holding
Funds holding: 253 → 256 (+3)
19% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 91
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
41% less capital invested
Capital invested by funds: $2.02B → $1.2B (-$821M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$66.1M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$35.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$10.8M |
| 4 |
SM
Samjo Management
New York
|
+$7.85M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$7.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$40.1M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$28.5M |
| 3 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$12.7M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$8.76M |
| 5 |
Goldman Sachs
New York
|
-$7.17M |
NEO Hedge Fund Activity: Q1 2025 in Review
256 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q1 2025, worth a combined $1.2B — down 41% from $2.02B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NEO positions and 35 closed out — a net gain of 7 holders — while 74 added to existing stakes and 91 trimmed.
The largest buyer was Millennium Management, adding an estimated $66.1M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $40.1M.
- 256 institutional investors held NeoGenomics (NEO) as of Q1 2025, up from 253 in Q4 2024.
- Funds reported $1.2B of NeoGenomics stock for Q1 2025, down 41% quarter-over-quarter.
- 42 funds opened new NeoGenomics positions in Q1 2025 and 35 closed out, a net change of +7 holders.
- The largest NeoGenomics buyer in Q1 2025 was Millennium Management, an estimated $66.1M added.
- The largest NeoGenomics seller in Q1 2025 was T. Rowe Price Investment Management, an estimated $40.1M sold.
Based on aggregated 13F filings for Q1 2025.